Ironwood(IRWD) - 2024 Q1 - Earnings Call Presentation
Ironwood(IRWD)2024-05-09 21:53
16 20 month Long-Term Safety and Durability 42 patients with PBC Randomized, Double-blinded, placebo-controlled, parallel assignment Doses: Placebo, CNP-104 4mg/kg, CNP-104 8mg/kg IV Infusion on Days 1 and 8 10 | --- | --- | --- | |--------------------------------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Sravan Emany Commercial Update, Q1 2024 Financial Highlights and Revised FY 2024 Guidance | | | | | | | ...